Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Biological Safety Testing Market 2017-2021: Growing Biotechnology & Pharmaceutical Industries Drive Growth - Research and Markets

Research and Markets
Posted on: 03 Oct 17

The "Global Biological Safety Testing Market 2017-2021" report has been added to Research and Markets' offering.

The global biological safety testing market is forecast to grow at a CAGR of 11.12% during the period 2017-2021.

The report, Global Biological Safety Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is International conferences promoting best practices of biosafety. There have been several collaborations to improve biosafety procedures and protocols. These collaborations organize annual events that discuss recent developments, discoveries, process improvement tools and techniques, and recommendations for industries. The oldest organization that promoted biosafety and improves protocols around the world is the ABSA. It was found in 1984 to promote biosafety as a scientific discipline and address the growing needs of biosafety professionals across the world. It aims to provide a professional association that represents the interests and needs of the practitioners of biological safety.

One of the major drivers for this market is the growing biotechnology and pharmaceutical industries. Biological safety testing is essential to ensure the safety of finished products in the biotechnology and pharmaceutical industries. Regulatory compliance and ensuring the production of products that are free from contaminations are essential for the success of pharmaceutical and biotechnology companies. Regulatory organizations require pharmaceutical products to comply with standard regulatory procedures. Due to the growing number of biopharmaceuticals, the demand for biological safety testing will increase during the forecast period. Therefore, the growth of the biotechnology and pharmaceutical industries will drive the growth of the global biological safety testing market.

Key vendors

  • Merck
  • Lonza
  • SGS
  • Thermo Fisher Scientific

Other prominent vendors

  • Air Science
  • Avance Biosciences
  • BSL Bioservice
  • Charles River Laboratories
  • Esco Micro
  • Nordic Scientific & Natural Solutions
  • NuAire
  • WuXi Biologics

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Segmentation By Offering

Part 07: Segmentation By Geography

Part 08: Decision Framework

Part 09: Drivers And Challenges

Part 10: Market Trends

Part 11: Vendor Landscape

Part 12: Key Vendor Analysis

Part 13: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/847kmd/global_biological

View source version on businesswire.com: http://www.businesswire.com/news/home/20171002005708/en/

Business Wire
www.businesswire.com

Last updated on: 03/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.